EPO 3000 IU | 10-Vial Kit | Erythropoietin | Erythropoiesis & Hypoxia Research

{“@context”: “https://schema.org”, “@type”: “FAQPage”, “mainEntity”: [{“@type”: “Question”, “name”: “How do I reconstitute this peptide?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Add 1–2mL bacteriostatic water to the lyophilized vial by directing water down the inner wall of the vial. Swirl gently until the powder fully dissolves — do not shake or vortex. The solution should be clear and colourless. Use immediately or refrigerate at 2–8°C.”}}, {“@type”: “Question”, “name”: “How should this peptide be stored?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Store lyophilized peptide vials at −20°C for long-term storage. Once reconstituted, store at 2–8°C (refrigerator) and use within 21–28 days. Avoid repeated freeze-thaw cycles, direct light, and heat exposure.”}}, {“@type”: “Question”, “name”: “What purity is this QSC compound and how is it verified?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “All QSC compounds are tested to ≥99% purity by HPLC peak area analysis on every production batch. Molecular identity is confirmed by mass spectrometry. A Certificate of Analysis (COA) is published on the product page and independently verifiable at verify.janoshik.com using the batch reference number.”}}]}

What is EPO (Erythropoietin)??

Erythropoietin (EPO, CAS 11096-26-7) is a 30.4 kDa glycoprotein hormone produced primarily by renal peritubular cells in response to hypoxia. Recombinant human EPO (rhEPO) binds the homodimeric EPO receptor (EPOR) on erythroid progenitor cells, activating JAK2/STAT5, PI3K/Akt, and MAPK signalling pathways — promoting red blood cell proliferation, differentiation, and survival. Beyond erythropoiesis, EPO research has expanded into neuroprotection, cardioprotection, and tissue ischaemia models through EPOR expression in non-haematopoietic tissues.

Research Applications

Quick Specs

Certificate of Analysis (COA)

Frequently Asked Questions